Skip to content
Preprint via OpenAlex

Mechanism suppressing proteostasis collapse in pluripotent stem cells and its demise in Huntington’s disease

Seda Koyuncu

Kölner Universitäts PublikationsServer (Universität zu Köln) · 2019

Abstract

With the significant extension in human life expectancy during the last decades, the number of older people is increasing dramatically. As a consequence, the incidence of age-related diseases such as cancer, neurodegenerative and cardiovascular diseases is also increasing. Our ever-aging population also has considerable social and economic impact. Therefore, understanding the underlying molecular mechanisms of the aging process is of central importance to improve the quality of life and develop novel therapeutic approaches for aging-related diseases. \n A decline in protein homeostasis (proteostasis(definition)) in somatic cells is a hallmark of aging. On the other hand, pluripotent stem cells such as human embryonic stem cells (hESCs) have shown to be immortal in culture and do not age, correlating with higher proteostasis mechanism. Thus, we hypothesized that understanding the regulation of the proteostasis network in pluripotent stem cells may provide valuable information for the better understanding of pluripotent stem cell identity and the aging process. \n In the first part of this study, we aimed to investigate how proteostasis pathways regulate hESC identity and function. hESCs have higher proteasome activity which is essential to maintain their self-renewal and pluripotency as well as their ability to differentiate. However, the underlying mechanisms by which enhanced proteasome activity regulates hESCs identity and function remain unknown. We hypothesized that increased proteasome activity could be essential to maintain proper concentration of many regulatory proteins. Since E3 ubiquitin ligases are responsible for the ubiquitin transfer to the specific substrate, we first identify which E3 ligases are up-regulated in hESCs compared with their differentiated counterparts. We found that some HECT-domain E3 enzymes such as HERC2 and UBE3A and some RING-domain E3 enzymes such as UBR7 and RNF181 are highly expressed in hESCs. Our interactome data indicates a possible link of these enzymes with hESC identity function. Interestingly, loss of different up-regulated E3 ligases leads to significant changes at both the transcriptome and proteome of hESCs. Nevertheless, these changes do not have strong effect on either pluripotency markers or differentiation capacity. On the contrary, by using a shot label-free proteomics approach, we show that global proteasome inhibition induces an alteration in key biological processes of hESCs identity such as protein synthesis, RNA biogenesis, telomere(definition) function. Therefore, our data suggests that enhanced proteasome activity is connected with other biological pathways of hESCs identity. \n In the second part of this study, we aimed to investigate how enhanced proteasome activity determines proteostasis of mutant HTT (mHTT) in pluripotent stem cells by specifically focusing on the intrinsic E3 ubiquitin ligase network. Proteostasis is essential for organismal development and cell function. Impairment of proteostasis leads to accumulation of damaged, misfolded and aggregated proteins, a process linked with the onset of age-related diseases such as Huntington’s disease (HD). HD is caused by abnormal expansions of polyglutamine repeats (polyQ) in the Huntingtin protein, leading to its aggregation and concomitant toxicity. Remarkably, the length of pathological polyQ does not influence survival, self-renewal and pluripotency of induced pluripotent stem cells (iPSCs) derived from HD patients (HD-iPSCs). These results suggest that iPSCs might have enhanced mechanisms to maintain proteostasis of mutant HTT. Here, we examined the mechanisms by which iPSCs maintain proteostasis of HTT. We find that proteasome activity determines HTT levels and prevents the accumulation of polyQ aggregates in HD-iPSCs. Notably, iPSCs have increased levels of the E3 ubiquitin ligase UBR5, which interacts with HTT and regulates the degradation of both mutant and wild-type HTT protein levels. Moreover, loss of UBR5 results in accumulation of HTT protein as well as polyQ-expanded aggregates in HD-iPSCs. Furthermore, we find that knockdown of the orthologue of UBR5 hastens polyQ-expanded aggregation and neurotoxicity in a C. elegans model of HD. Strikingly, ectopic expression of UBR5 is sufficient to induce polyubiquitination and degradation of mutant HTT, decreasing polyQ aggregates in HD cell models. Moreover, higher UBR5 expression determines global proteostasis of iPSCs preventing the aggregation of misfolded proteins ensued from normal metabolism. Thus, our data put UBR5 as a novel modulator of super-vigilant proteostasis of iPSCs.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
Canonical
link ↗
Fetched
2026-10-05 MST

Cite this

APA
Koyuncu, S. (2019). Mechanism suppressing proteostasis collapse in pluripotent stem cells and its demise in Huntington’s disease. <em>Kölner Universitäts PublikationsServer (Universität zu Köln)</em>. https://openalex.org/W2970956937
Vancouver
Koyuncu S. Mechanism suppressing proteostasis collapse in pluripotent stem cells and its demise in Huntington’s disease. Kölner Universitäts PublikationsServer (Universität zu Köln). 2019.
BibTeX
@unpublished{seda2019Mechan, title = {Mechanism suppressing proteostasis collapse in pluripotent stem cells and its demise in Huntington’s disease}, author = {Seda Koyuncu}, journal = {Kölner Universitäts PublikationsServer (Universität zu Köln)}, year = {2019}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings